Director/PDMR Shareholding

 

TIDMGWP 
 
RNS Number : 6199X 
GW Pharmaceuticals PLC 
08 December 2010 
 
 
         GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company") 
 
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 
Porton Down, UK, 8  December 2010: GW Pharmaceuticals (AIM: GWP) hereby provides 
notification that the Company has today been notified of the following share 
transactions entered into today by Mr Thomas Lynch, a non-executive Director and 
Dr Geoffrey Guy, a Director and Executive Chairman of the Company. 
 
Mr Thomas Lynch purchased 47,665 ordinary shares of 0.1p each from Dr Geoffrey 
Guy. This transaction between Directors, which equates to 0.04% of the issued 
ordinary share capital of the company, took place at the prevailing market price 
of 104.9 pence per share. 
 
Dr Guy has also today transferred 4,256 ordinary shares of 0.1p each, equating 
to less than 0.01% of the issued ordinary share capital of the company, into his 
personal pension scheme. This transaction took place at the prevailing market 
price of 106.75 pence per share. 
 
Following this notification: 
 
Mr Lynch's holding in the shares of GW Pharmaceuticals PLC is 47,665 ordinary 
shares, amounting to 0.04% of shares in issue. 
 
Dr Guy retains a beneficial interest in 18,306,783 ordinary shares, amounting to 
13.95% of the shares in issue. 
 
The total number of shares outstanding in the Company is 131,243,292 ordinary 
shares of 0.1p each. 
 
For further information, please contact: 
 
GW Pharmaceuticals PLC                                                +44 
(0)1980 557 000 
Adam George, Company Secretary 
 
Peel Hunt Ltd (Nominated Adviser) 
James Steel/Vijay Barathan                                               +44 
(0) 207 418 8900 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSLLFEEFLLTIII